Medical Journals

Efficient Conversion of Es Cells into Myogenic Lineage Using the Gene-inducible System.

Authors:
  • Ozasa Shiro
  • Kimura Shigemi
  • Ito Kaori
  • Ueno Hiroe
  • Ikezawa Makoto
  • Matsukura Makoto
  • Yoshioka Kowashi
  • Araki Kimi
  • Yamamura Ken-ich
  • Abe Kuniya
  • Niwa Hitoshi
  • Miike Teruhisa

From: Department of Child Development, Kumamoto University Graduate School, 1-1-1 Honjo, Kumamoto City, Kumamoto 862-8556, Japan.

Biochemical and biophysical research communications

  • Publish Date: Jun 2007
  • ISSN: 0006-291X
  • Volume: 357
  • Issue: 4
  • Pages: 957-63
  • Medium: Print
  • Language: English
  • Citation (JAMA): Ozasa Shiro, Kimura Shigemi, Ito Kaori, et al. Efficient Conversion of Es Cells into Myogenic Lineage Using the Gene-inducible System.. Biochem. Biophys. Res. Commun. Jun 2007;357:957-63

Abstract

We established genetically engineered ES (ZHTc6-MyoD) cells that harbor a tetracycline-regulated expression vector encoding myogenic transcriptional factor MyoD, for the therapy of muscle diseases, especially Duchenne muscular dystrophy (DMD). Almost all the ZHTc6-MyoD cells were induced into muscle lineage after removal of tetracycline. The undifferentiated ZHTc6-MyoD cells are Sca-1+ and c-kit+, but CD34-, all well-known markers for mouse hematopoietic stem cells. In addition, they are able to maintain themselves in the undifferentiated state, even after one month of culture. Therefore, it is possible to obtain a large quantity of ZHTc6-MyoD cells in the undifferentiated state that maintain the potential to differentiate only into muscle lineage. Additionally, at two weeks post-injection of these cells into muscle of mdx, a model mouse of DMD, clusters of dystrophin-positive myofibers were observed at the injection site. Therefore, ES cells have considerable therapeutic potential for treating muscle diseases.

Mesh Headings (Keywords): Animals, Cell Culture Techniques, Cells, Cultured, Embryonic Stem Cells, Genetic Engineering, Mice, Muscle Cells, MyoD Protein, Tissue Engineering


Check for Full Text / PubMed Unique Identifier (PMID): 17466266


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.